MDGL

Madrigal Pharmaceuticals Inc.

Price

$540.16

return (12m)

42.32%

p/e

-45.30

p/bv

28.12

DIVIDEND YIELD

0.00%

MDGL price

Madrigal Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MDGL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.52%

3 months

5.17%

1 year

42.32%

2 years

110.40%

5 years

543.97%

10 years

5,695.71%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MDGL

Valuation

P/E

-45.30

Sector -4.38

Industry -4.38

P/BV

28.12

Sector 2.02

Industry 2.02

P/Revenue (PSR)

11.47

Sector -4.40

Industry -4.40

EV/EBITDA

-286.76

Sector -263.09

Industry -263.09

EV/EBIT

-284.58

Sector -702.90

Industry -702.90

P/EBITDA

-50.42

Sector -4.39

Industry -4.39

P/EBIT

-50.16

Sector -4.73

Industry -4.73

P/Total Assets

11.83

Sector 1.49

Industry 1.49

P/Net Current Assets

30.79

Sector -11.70

Industry -11.70

P/Working Capital

17.85

Sector -3.19

Industry -3.19

EPS

-11.21

Sector -2.14

Industry -2.14

BVPS

18.06

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

91.48%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-13.62%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-13.73%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-25.13%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-25.32%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.29

Sector 0.03

Industry 0.03

Profitability

ROE

-62.08%

Sector -65.14%

Industry -65.14%

ROA

-26.12%

Sector -65.53%

Industry -65.53%

ROIC

-219.80%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.20

Sector 2.90

Industry 2.90

Net Debt / EBITDA

10.04

Sector -6.07

Industry -6.07

Net Debt / EBIT

9.96

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.95

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.65

Sector -0.05

Industry -0.05

Equity/Assets

0.42

Sector 0.41

Industry 0.41

Liabilities/Assets

0.58

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

6.09%

Sector -

Industry -

Fundamentals MDGL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MDGL Madrigal Pharmaceuticals Inc.	$540.16	38.00%	0.00%	-45.30	28.12	-62.08%	-25.32%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MDGL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2007

Time since IPO - 19 years

42

Employees

Madrigal Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $14.73 billion, with shareholders equity totaling $523.72 million.

The company employs approximately 42 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Madrigal Pharmaceuticals Inc. reported $1.28 billion in revenue, generating net income of $-325.10 million.

Key financial metrics include a P/E ratio of -45.30, a price-to-book (P/B) ratio of 28.12, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MDGL.

Market cap

$14.73 billion

Net worth

$523.72 million

$523,720,000.00

Assets

$1.24 billion

$1,244,640,000.00

Total Shares Outstanding

29.00 million

29,000,000

Average Daily Trading Volume

$382.20 Thousand

$382,201.76

Sector

Health Care

Industry

Biotechnology

MDGL

MDGL revenue and profits

Financial Results MDGL

DRAG THE FRAME TO SEE MORE DATA

MDGL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Madrigal Pharmaceuticals (MDGL) today?

A cotação de Madrigal Pharmaceuticals (MDGL) hoje está em US$ 540.16, com uma variação de 42.32% em relação ao último ano. A cotação de Madrigal Pharmaceuticals (MDGL) iniciou o ano negociando na casa dos US$ 582.34 e hoje está em US$ 540.16. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Madrigal Pharmaceuticals (MDGL) e dados de ações do Ibovespa e mercados internacionais.

Quando Madrigal Pharmaceuticals (MDGL) paga dividendos?

Madrigal Pharmaceuticals (MDGL) não distribuiu dividendos no último ano.

Is Madrigal Pharmaceuticals (MDGL) a good investment?

Atualmente, Madrigal Pharmaceuticals (MDGL) está cotada a US$ 540.16, com um P/L de -45.30, representando um desvio de -2,779% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 42.32 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 42.32%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Madrigal Pharmaceuticals (MDGL) stock?

Investir em ações de Madrigal Pharmaceuticals (MDGL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Madrigal Pharmaceuticals (MDGL) yield today?

A rentabilidade de Madrigal Pharmaceuticals (MDGL) foi de -0.52% no último mês, 42.32% no último ano e 543.97% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Madrigal Pharmaceuticals (MDGL) hoje, o investimento total seria de US$ 54,016.00, com base na cotação atual de US$ 540.16.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 76,875.57
Em 5 anos: US$ 347,846.84
Em 10 anos: US$ 3,130,610.71

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MDGL

Madrigal Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MDGL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MDGL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Inc.

United States

15 years

2007

42

PROFIT X PRICE MDGL

Financial Results MDGL

MDGL cash flow

Asset, Revenue and Profit Growth - MDGL

MDGL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions